TrialGynecologic oncology2024

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Giorgio Valabrega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.